Peiyuan Mu

Papers

1

Total Citations

15

H-Index

1

About

Dr. Peiyuan Mu is a pioneering surgeon whose work centers on advancing minimally invasive techniques for complex hepatobiliary malignancies, particularly hilar cholangiocarcinoma. His landmark 2014 study, cited 15 times, documents the first reported use of Da Vinci robotic surgery to treat hilar cholangiocarcinoma with deep jaundice—a condition traditionally considered high-risk for immediate resection. In a patient with a total bilirubin of 635 µmol/L, Dr. Mu performed a two-stage robotic procedure: initial drainage followed by radical resection, demonstrating that robotic assistance can safely manage severe obstructive jaundice while achieving oncologic clearance. This contribution challenged conventional two-stage open surgery paradigms, offering a less invasive alternative with potential for reduced morbidity. Dr. Mu’s work has helped establish robotic platforms as viable tools in hepatobiliary surgery, expanding treatment options for patients with advanced disease. His research underscores a commitment to integrating cutting-edge technology into clinical practice, improving outcomes for some of the most challenging surgical cases.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Surgery Twice Performed in the Treatment of Hilar Cholangiocarcinoma With Deep Jaundice
15 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 10

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago